Drug Shortage Report for AMIKACIN SULFATE INJECTION

Last updated on 2025-10-23 History
Report ID 261147
Drug Identification Number 02486717
Brand name AMIKACIN SULFATE INJECTION
Common or Proper name AMIKACIN SULFATE INJECTION
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) AMIKACIN
Strength(s) 250MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 10 x 2mL vial / fiole
ATC code J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2025-07-09
Estimated end date 2025-11-21
Actual end date 2025-10-22
Shortage status Resolved
Updated date 2025-10-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2025-10-23 English Compare
v15 2025-10-22 French Compare
v14 2025-10-22 English Compare
v13 2025-10-01 French Compare
v12 2025-10-01 English Compare
v11 2025-09-03 French Compare
v10 2025-09-03 English Compare
v9 2025-08-26 French Compare
v8 2025-08-26 English Compare
v7 2025-07-10 English Compare
v6 2025-07-09 French Compare
v5 2025-07-09 English Compare
v4 2025-07-09 English Compare
v3 2025-07-09 English Compare
v2 2025-06-26 French Compare
v1 2025-06-26 English Compare

Showing 1 to 16 of 16